Loading asset research
Achieve Life Sciences Inc. Common Shares
ACHVNasdaq · USD · StocksQuote as of · Exchange session not verified$7.06
-3.02%
Today
ACHV
Loading 1D prices…
Market cap
$726.5M
Volume
1.5M
52w high
$8.6452w low
$2.62Company profile
Achieve Life Sciences Inc. Common Shares
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
Sector
Health Care
Industry
In Vitro & In Vivo Diagnostic Substances
Exchange
Nasdaq
Display currency
USD
Location
Bothell, WA, United States
Employees
28
Fiscal year end
1231
CIK
949858
Session & valuation
Open$7.38
Previous close$7.28
Day high$7.44
Day low$7.01
30-day avg. volume1.5M
Outstanding shares102.9M
Diluted EPS-$1.25
Latest annual period
P/E (trailing)-5.65
P/E (forward)-11.09
Price / book-49.37
Beta2.25
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2835
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| QDELQuidelOrtho Corporation Common Stock | $807.8M | $2.7B | -41.45% | -$16.69 | -3.00% | Sell |
| TKNOAlpha Teknova Inc. Common Stock | $360.2M | $40.5M | -42.59% | -$0.32 | -2.89% | Buy |
| MYGNMyriad Genetics Inc. Common Stock | $327.1M | $824.5M | -44.39% | -$3.95 | +1.79% | Sell |
| NTLAIntellia Therapeutics Inc. Common Stock | $1.6B | $67.7M | -609.85% | -$3.81 | -1.63% | Hold |
| NNNNAnbio Biotechnology Class A Ordinary Shares | $278.3M | $8.6M | +74.06% | $0.147 | -2.61% | Unrated |